155 related articles for article (PubMed ID: 36508261)
1.
Zou J; Zhang H; Wu Z; Hu W; Zhang T; Xie H; Huang Y; Zhou H
Cancer Biother Radiopharm; 2024 Apr; 39(3):223-235. PubMed ID: 36508261
[No Abstract] [Full Text] [Related]
2. A novel oncogene trigger transposable element derived-1 promotes oral squamous cell carcinoma progression via evoking immune inhibition.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Mol Carcinog; 2023 Aug; 62(8):1213-1227. PubMed ID: 37144838
[TBL] [Abstract][Full Text] [Related]
3. RBBP4 promotes colon cancer malignant progression
Li YD; Lv Z; Zhu WF
World J Gastroenterol; 2020 Sep; 26(35):5328-5342. PubMed ID: 32994691
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
5. TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer.
Yin L; Yan J; Wang Y; Sun Q
J Cell Biochem; 2019 Jun; 120(6):9758-9767. PubMed ID: 30548305
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
[TBL] [Abstract][Full Text] [Related]
7. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
8. HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway.
Gu Y; Gu J; Shen K; Zhou H; Hao J; Li F; Yu H; Chen Y; Li J; Li Y; Liang H; Dong Y
Exp Cell Res; 2020 Oct; 395(2):112238. PubMed ID: 32822724
[TBL] [Abstract][Full Text] [Related]
9. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
11. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
12. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
Cheng B; Rong A; Zhou Q; Li W
J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
[TBL] [Abstract][Full Text] [Related]
14. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
[TBL] [Abstract][Full Text] [Related]
15. Exploring Cancer Dependency Map genes and immune subtypes in colon cancer, in which
Zhang G; Feng Z; Zeng Q; Huang P
Aging (Albany NY); 2023 Jul; 15(13):6400-6428. PubMed ID: 37441804
[TBL] [Abstract][Full Text] [Related]
16. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
18. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M; Zhu L; Li L; Kang C
Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
[TBL] [Abstract][Full Text] [Related]
19. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
Chai WX; Sun LG; Dai FH; Shao HS; Zheng NG; Cai HY
Pathol Res Pract; 2019 Oct; 215(10):152593. PubMed ID: 31471104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]